D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 72 Citations 20,663 136 World Ranking 14395 National Ranking 7496

Research.com Recognitions

Awards & Achievements

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Surgery

His primary areas of investigation include Transplantation, Surgery, Bone marrow, Internal medicine and Leukemia. His Transplantation study incorporates themes from Umbilical cord, Refractory and Chemotherapy. His Surgery research incorporates elements of Histocompatibility and Confidence interval.

His studies in Bone marrow integrate themes in fields like Chronic myelogenous leukemia, Haematopoiesis, Chemoradiotherapy and Disease. The Internal medicine study which covers Gastroenterology that intersects with Respiratory failure. His research in Leukemia intersects with topics in Cancer research and Cyclophosphamide, Fludarabine.

His most cited work include:

  • Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. (1213 citations)
  • Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. (807 citations)
  • Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy (762 citations)

What are the main themes of his work throughout his whole career to date?

Philip B. McGlave mostly deals with Internal medicine, Transplantation, Surgery, Immunology and Bone marrow. Philip B. McGlave has included themes like Gastroenterology and Oncology in his Internal medicine study. His Transplantation research integrates issues from Umbilical cord, Leukemia and Cyclophosphamide, Fludarabine.

His Surgery research is multidisciplinary, incorporating elements of Relative risk, Confidence interval and Disease. Philip B. McGlave interconnects Natural killer cell and Haematopoiesis in the investigation of issues within Immunology. His research investigates the connection between Bone marrow and topics such as Unrelated Donor that intersect with issues in Quality of life.

He most often published in these fields:

  • Internal medicine (51.90%)
  • Transplantation (49.37%)
  • Surgery (39.87%)

What were the highlights of his more recent work (between 2006-2020)?

  • Internal medicine (51.90%)
  • Transplantation (49.37%)
  • Immunology (34.18%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Transplantation, Immunology, Fludarabine and Surgery. His Internal medicine research integrates issues from Gastroenterology, Umbilical cord and Oncology. His Umbilical cord study combines topics in areas such as Hematology, Cord Blood Stem Cell Transplantation and Immunotherapy.

His Transplantation study integrates concerns from other disciplines, such as Pharmacokinetics, Cumulative incidence and Histocompatibility. In his study, Bone marrow and HLA Mismatch is strongly linked to Lower risk, which falls under the umbrella field of Histocompatibility. His studies in Fludarabine integrate themes in fields like Transplantation Conditioning, Myeloid leukemia and Lymphoma.

Between 2006 and 2020, his most popular works were:

  • Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. (807 citations)
  • Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease (457 citations)
  • Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: Report from the Bone Marrow Transplant Survivor study (371 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Immune system

His main research concerns Internal medicine, Transplantation, Umbilical cord, Surgery and Immunology. As a part of the same scientific study, Philip B. McGlave usually deals with the Internal medicine, concentrating on Gastroenterology and frequently concerns with Total body irradiation. Philip B. McGlave combines subjects such as Oncology, Relative risk, Standardized mortality ratio, Histocompatibility and Survival analysis with his study of Transplantation.

His Umbilical cord research incorporates elements of Hematology and Cord Blood Stem Cell Transplantation. The Immunology study combines topics in areas such as Cell and Natural killer cell. His work is dedicated to discovering how Leukemia, Cyclophosphamide are connected with Survival rate and other disciplines.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.

Jeffrey S. Miller;Yvette Soignier;Angela Panoskaltsis-Mortari;Sarah A. McNearney.
Blood (2005)

1407 Citations

Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program

Nancy A. Kernan;Glenn Bartsch;Robert C. Ash;Patrick G. Beatty.
The New England Journal of Medicine (1993)

1229 Citations

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

Juliet N. Barker;Daniel J. Weisdorf;Todd E. DeFor;Bruce R. Blazar.
Blood (2005)

1023 Citations

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

Claudio G. Brunstein;Jeffrey S. Miller;Qing Cao;David H. McKenna.
Blood (2011)

956 Citations

Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease

John E. Wagner;Joseph Rosenthal;Joseph Rosenthal;Robert Sweetman;Robert Sweetman;Xiao Ou Shu;Xiao Ou Shu.
Blood (1996)

790 Citations

Umbilical cord blood transplantation after nonmyeloablative conditioning: Impact on transplantation outcomes in 110 adults with hematologic disease

Claudio G. Brunstein;Juliet N. Barker;Daniel J. Weisdorf;Todd E. DeFor.
Blood (2007)

561 Citations

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: Report from the Bone Marrow Transplant Survivor study

Smita Bhatia;Liton Francisco;Andrea Carter;Can Lan Sun.
Blood (2007)

477 Citations

Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome.

Daniel Weisdorf;Robert Haake;Bruce Blazar;Wesley Miller.
Blood (1990)

469 Citations

Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.

John H. Kersey;Daniel Weisdorf;Mark E. Nesbit;Tucker W. LeBien.
The New England Journal of Medicine (1987)

449 Citations

Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation.

Daniel Weisdorf;Robert Hakke;Bruce Blazar;Wesley Miller.
Transplantation (1991)

365 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Philip B. McGlave

Daniel J. Weisdorf

Daniel J. Weisdorf

University of Minnesota

Publications: 214

Jeffrey S. Miller

Jeffrey S. Miller

University of Minnesota

Publications: 160

John E. Wagner

John E. Wagner

University of Minnesota

Publications: 152

Bruce R. Blazar

Bruce R. Blazar

University of Minnesota

Publications: 150

Claudio Anasetti

Claudio Anasetti

Fred Hutchinson Cancer Research Center

Publications: 128

Richard E. Champlin

Richard E. Champlin

The University of Texas MD Anderson Cancer Center

Publications: 111

Rainer Storb

Rainer Storb

Fred Hutchinson Cancer Research Center

Publications: 109

Joseph H. Antin

Joseph H. Antin

Harvard University

Publications: 103

Paul J. Martin

Paul J. Martin

Fred Hutchinson Cancer Research Center

Publications: 99

Sergio Giralt

Sergio Giralt

Memorial Sloan Kettering Cancer Center

Publications: 96

Elizabeth J. Shpall

Elizabeth J. Shpall

The University of Texas MD Anderson Cancer Center

Publications: 82

Mary M. Horowitz

Mary M. Horowitz

Center for International Blood and Marrow Transplant Research

Publications: 82

Todd E. DeFor

Todd E. DeFor

University of Minnesota

Publications: 81

Eliane Gluckman

Eliane Gluckman

Université Paris Cité

Publications: 78

Arnon Nagler

Arnon Nagler

Sheba Medical Center

Publications: 77

Gérard Socié

Gérard Socié

Université Paris Cité

Publications: 71

Trending Scientists

Milan Sonka

Milan Sonka

University of Iowa

Albert Rizzo

Albert Rizzo

University of Southern California

Hussein A. Kazem

Hussein A. Kazem

Sohar University

Ching-Hua Huang

Ching-Hua Huang

Georgia Institute of Technology

Asao Fujiyama

Asao Fujiyama

National Institute of Genetics

Jerry O. Wolff

Jerry O. Wolff

University of Memphis

Susan Band Horwitz

Susan Band Horwitz

Albert Einstein College of Medicine

Daniel Metzger

Daniel Metzger

University of British Columbia

Edwin G. Krebs

Edwin G. Krebs

University of Washington

Raul Urrutia

Raul Urrutia

Medical College of Wisconsin

Angel L. Corbí

Angel L. Corbí

Spanish National Research Council

Alexander A. Prokopenko

Alexander A. Prokopenko

University of South Carolina

Taco J. De Vries

Taco J. De Vries

VU University Medical Center

Rudolph L. Leibel

Rudolph L. Leibel

Columbia University

Peter M. Garnavich

Peter M. Garnavich

University of Notre Dame

Something went wrong. Please try again later.